Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection

Peptides

Volumn 27, Issue 6, 2006, Pages 1210-1216

  Cirioni, Oscar ^a   Giacometti, Andrea ^a   Ghiselli, Roberto ^a   Kamysz, Wojciech ^b   Orlando, Fiorenza ^c   Mocchegiani, Federico ^a   Silvestri, Carmela ^a   Licci, Alberto ^a   Chiodi, Leonardo ^a   Łukasiak, Jerzy ^b   Saba, Vittorio ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c INRCA   (Italy)

Author keywords

Antibiotic lock technique; Antimicrobial peptides; Biofilm; Citropin 1.1; CVC

Indexed keywords

ANTIBIOTIC AGENT; CITROPIN; MINOCYCLINE; POLYSTYRENE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BIOFILM; BLOOD CULTURE; CATHETER INFECTION; CELL ADHESION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; HYDROPHOBICITY; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPERIOR CAVA VEIN; TISSUE CULTURE;

AMPHIBIAN PROTEINS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; CATHETERIZATION; CATHETERIZATION, CENTRAL VENOUS; MALE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POLYSTYRENES; RATS; RATS, WISTAR; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 33646768929     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.10.007     Document Type: Article

References (35)

1. Atela I., Coll P., Rello J., Barrio J., March F., Sanchez F., et al. Serial surveillance cultures of skin and catheter hub specimens from critically ill patients with central venous catheters: molecular epidemiology of infection and implications for clinical management and research. J Clin Microbiol 35 (1997) 1784-1790
2. Benoit J.L., Carandang G., Sitrin M., and Arnow P. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 24 (1997) 743-744
3. Berrington A., and Gould F.K. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 48 (2001) 597-603
4. Bevins C.L., and Zasloff M. Peptides from frog skin. Ann Rev Biochem 59 (1990) 395-414
5. Capdevila J.A., Gavalda J., and Pahissa A. Antibiotic-lock technique: usefulness and controversies. Antimicrob Infect Dis Newsl 15 (1996) 9-13
6. Chen H., Zhang Z., Chen Y., Brook M.A., and Sheardown H. Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide). Biomaterials 26 (2005) 2391-2399
7. Christensen G.D., Simpson W.A., Younger J.J., Baddour L.M., Barrett F.F., Melton D.M., et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22 (1985) 996-1006
8. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Villanova, PA; 2003.
9. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilm: a common cause of persistent infections. Science 284 (1999) 1318-1322
10. Donlan R.M., and Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2002) 167-193
11. Doyle J., Brinkworth C.S., Wegener K.L., Carver J.A., Llewellin L.E., Olver I.N., et al. nNOS inhibition, antyimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. Eur J Biochem 270 (2003) 1141-1153
12. Eliopoulos G.M., and Moellering Jr. R.C. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in laboratory medicine (1996), Williams & Wilkins, Baltimore, MD 330-393
13. Fields G.B., and Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35 (1990) 161-214
14. Fux C.A., Costerton J.W., Stewart P.S., and Stoodley P. Survival strategies of infectious biofilm. Trends Microbiol 13 (2005) 34-40
15. Fux C.A., Stoodley P., Hall-Stoodley L., and Costerton J.W. Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1 (2003) 667-683
16. Hall-Stoodley L., Costerton J.W., and Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2 (2004) 95-108
17. Hancock R.E.W. Peptides antibiotics. Lancet 349 (1997) 418-422
18. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 (2001) 156-164
19. Hancock R.E.W., and Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 43 (1999) 1317-1323
20. Hannan M., Juste R.N., Umasanker S., Glendenning A., Nightingale C., Azadian B., et al. Antiseptic-bonded central venous catheters and bacterial colonization. Anaesthesia 54 (1999) 868-872
21. Harvey R.A., Alcid D.V., and Greco R.S. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride. Surgery 92 (1982) 504-512
22. Maki D.G. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno A.I., and Waldvogel F.A. (Eds). Infections associated with indwelling medical devices. 2nd ed. (2004), ASM Press, Washington, DC 155-212
23. Marciante K.D., Veenstra D.L., Lipsky B.A., and Saint S. Which antimicrobial impregnated central venous catheter should we us? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 31 (2003) 1-8
24. McConnell S.A., Gubbins P.O., and Anaissie E.J. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection. Clin Infect Dis 37 (2003) 65-72
25. Mermel L.A., Farr B.M., Sheretz R.J., Raad I.I., O'Grady N., Harris J.S., et al. Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
26. Munson E.L., Heard S.O., and Doern G.V. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance. Chest 126 (2004) 1628-1635
27. Phaneuf M.D., Quist W.C., Bide M.J., and Lo Gerfo F.W. Modification of the polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities. J Appl Biomater 6 (1995) 289-299
28. Pittet D. Nosocomial bloodstream infections. In: Wenzel R.P. (Ed). Prevention and control of nosocomial infections. 3rd ed. (1997), Lippincott, Williams & Wilkins, Baltimore, MD 711-769
29. Raad I. Intravascular-catheter-related infection. Lancet 351 (1998) 893-898
30. Raad I., and Hanna H. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections. Support Care Cancer 7 (1999) 386-390
31. Rupp M.E., Fey P.D., and Longo G.M. Effect of LY33328 against vancomycin-resistant Enterococcus faecium in a rat model central venous catheter-associated infection model. J Antimicrob Chemother 47 (2001) 705-707
32. Shorr A.F., Humphreys C.W., and Helman D.L. New choices for central venous catheters. Potential financial implications. Chest 124 (2003) 275-285
33. Stepanovic S., Vukovic D., Dakic I., Savic B., and Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40 (2000) 175-179
34. Vaara M., and Porro M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother 40 (1996) 1801-1805
35. Wabnitz P.A., Bowie J.H., Wallace J.C., and Tyler M.J. The antibiotic citropin peptides from the Australian tre frog Litoria citropa. Structure determination using electrospray mass spectrometry. Rapid Commun Mass Spectrom 13 (1999) 1724-1732